Dr. Douglas Allan Receives co-funded grant from Alzheimer Society and Brain Canada
June 20, 2025
LSI researcher Dr. Douglas Allan has been awarded a Proof of Concept Grant through the Alzheimer Society Research Program, co-funded by Brain Canada Foundation.
This national initiative is investing $5.1 million in 37 promising dementia research projects in 2025. Dr. Allan’s project, “A universal platform for high volume genetic modifier testing in Tauopathy,” aims to accelerate the identification of harmful Tau gene mutations associated with dementia.
By developing a fruit fly system that uses high speed genetics, his team will sort benign from toxic human Tau mutations. This approach will not only help clinicians interpret genetic test results but also reveal critical regions of the Tau protein involved in neurodegeneration—laying the groundwork for more targeted and effective therapies.
Latest News
UBC enzyme technology clears first human test toward universal donor organs for transplantation
October 8, 2025
UBC launches world’s first mushroom-powered, waterless toilet with help from Hallam Lab
October 2, 2025
Dr. Kayla King awarded Royal Society’s Francis Crick Medal
September 16, 2025
Dr. Emilia Lim investigates wildfire smoke’s health toll with Genome BC funding
September 9, 2025
Dr. Steven Hallam named 2025 UBC Wall Research Award recipient
September 8, 2025
Dr. Yossef Av-Gay’s team reveals 70-year-old Parkinson’s drug’s promise against Tuberculosis
August 29, 2025
Building an inclusive TA training program in the life sciences
August 25, 2025
LSI researchers awarded funding in Spring 2025 CIHR project grant competition
July 21, 2025
Dr. Jayachandran Kizhakkedathu awarded New Frontiers in Research Fund – Exploration Grant
July 14, 2025
LSI researchers awarded funding through NSERC grants
July 11, 2025
Dr. Ivan Robert Nabi awarded Distinguished Achievement award by the UBC Faculty of Medicine
June 24, 2025
Dr. Douglas Allan Receives co-funded grant from Alzheimer Society and Brain Canada
June 20, 2025
LSI researchers receive national recognition for stem cell innovation
June 20, 2025
Dr. Mark Cembrowski awarded over $4.8 million to advance neuroscience research
June 18, 2025
Dr. Pieter Cullis profiled by CIHR for pioneering work in drug delivery and mRNA vaccines
May 29, 2025